Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Revenue: 2009-2024

Historic Revenue for RedHill Biopharma (RDHL) over the last 16 years, with Dec 2024 value amounting to $8.0 million.

  • RedHill Biopharma's Revenue fell 90.21% to $1.8 million in Q2 2023 from the same period last year, while for Jun 2023 it was $35.7 million, marking a year-over-year decrease of 52.42%. This contributed to the annual value of $8.0 million for FY2024, which is 23.17% up from last year.
  • According to the latest figures from FY2024, RedHill Biopharma's Revenue is $8.0 million, which was up 23.17% from $6.5 million recorded in FY2023.
  • RedHill Biopharma's 5-year Revenue high stood at $85.8 million for FY2021, and its period low was $6.5 million during FY2023.
  • For the 3-year period, RedHill Biopharma's Revenue averaged around $25.5 million, with its median value being $8.0 million (2024).
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 923.03% in 2020, then tumbled by 89.43% in 2023.
  • Yearly analysis of 5 years shows RedHill Biopharma's Revenue stood at $64.4 million in 2020, then surged by 33.25% to $85.8 million in 2021, then fell by 27.94% to $61.8 million in 2022, then tumbled by 89.43% to $6.5 million in 2023, then climbed by 23.17% to $8.0 million in 2024.